In multiple paradigms, animals given GLP-1 agonists reduced their substance intake by 40-60%, even when the substances were freely available
Ozempic is still the GLP-1 king, but Lilly is rapidly gaining market share, with its Q2 2024 sales reaching $3.01 billion compared to Novo Nordisks $5.38 billion
By suppressing appetite and giving people feelings of fullness, they are commonly able to maintain a calorie deficit, which is an important aspect of losing weight
13 , 14 , 15 , 16 ''It's critical for adults on weight loss regimens to prioritize good nutrition to ensure they get enough micronutrients and protein to preserve muscle mass while consuming limited calories,'' said Hakim Bouzamondo, MD, MSC, MBA, division vice president of Nutrition Research and Development at Abbott
The high fat content of ketogenic diets combined with delayed gastric emptying from GLP-1 therapy may exacerbate digestive discomfort
Bauer, P